Richard S. Shames, Chief Medical Officer at Protagonist Therapeutics, Inc (PTGX), sold 7,374 shares at $14.31 ($106K) on 2017-09-12, disclosed to the SEC on 2017-09-12.
Open-market sale of $106k PTGX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.31 | 3,687 | $53K | 50.0% |
| 2 | $14.31 | 3,687 | $53K | 50.0% |
| Total | $14.31 avg | 7,374 | $106K | 100% |
| Filing → |
| PTGX | SELL | 2017-12-27 | $145K | — | Filing → |
| PTGX | SELL | 2017-10-10 | $38K | — | Filing → |
| PTGX | SELL | 2017-08-30 | $26K | — | Filing → |